TeraBAT Overview
- Founded
-
2010
- Status
-
Private
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
3
TeraBAT General Information
Description
Developer of a disruptive detection platform based on terawaves technology. The company provides a platform that specializes in disease detection, disease diagnosis, breath analysis, exhaled breath biomolecule identification and patient care.
Contact Information
Website
www.terabat.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 6333 Dry Creek Parkway
- Niwot, CO 80503
- United States
+1 (720) 000-0000
TeraBAT Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TeraBAT Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Eyal Gerecht Ph.D | Co-Founder, President, Chief Technology Officer and Chief Executive Officer |
TeraBAT Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|